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Abstract
Globally, at least 140 million people are exposed to levels of arsenic greater than
the World Health Organization recommended standard of 10 µg/L (10 ppb) through their
drinking water and food. Epidemiological studies have correlated arsenic exposure during
embryonic and fetal development with reduced birth weight, as well as muscular and
neurodevelopmental deficits. The goal of the current study was to determine the
mechanisms by which a chronic, low-level arsenic exposure impairs cellular development
and differentiation. This was achieved by exposing P19 mouse embryonic stem cells
(mESC’s) to 0.1 μM arsenic (7.5 ppb), a concentration lower than the current drinking
water standard, continuously for 32 weeks.
The P19 stem cell line is commonly used in developmental studies as it can be
induced to form cells of all three germ layers. During the current study, a subset of cells
were induced to differentiate every 4 weeks of the 32-week arsenic exposure, to assess
whether arsenic impaired their ability to form mature cell lineages. Differentiating cells
were collected after 5 and 9 days to examine transcript and protein expression. Previous
studies of P19 cells exposed to higher arsenic concentrations (0.5 – 1 µM) reported robust
differences in cell morphology, as well as reductions of transcription factors involved in
neuronal differentiation, and increases in transcription factors crucial for maintaining
pluripotency.
In this study of 0.1 μM arsenic, only minor and inconsistent changes in morphology
were observed to result from exposure. However, arsenic induced consistent
overexpression of the pluripotency markers Oct4 and Sox2 by 1.4- to 1.8-fold beginning

ii

at week 8, while Sox2 protein expression was increased by 1.4 fold starting at week 16.
Elevated expression of pluripotency-associated transcription factors is commonly observed
in ESC’s, but also in cancer stem cells (CSC’s). Another feature of CSC’s are protein
expression patterns consistent with epithelial-mesenchymal transitions (EMT). A
prevailing hallmark of EMT is increased expression of the cell-to-cell adhesion molecule
N-cadherin, which is known to be induced by Sox2. Beginning at week 20, N-cadherin
levels remained significantly increased by 1.3- to 1.9 fold through the 32-week exposure.
Interestingly, as markers of pluripotency and EMT increased, the expression of the
doublecortin (DCX) gene, a microtubule-associated protein of immature neurons, was
consistently reduced throughout the exposure with significance of up to 2-fold decreases
shown at weeks 8 and 20. However, transcript levels of Nrf2 and Hmox1, markers of
oxidative stress, and MyoD, a marker of myogenesis, appeared to be unaltered throughout
the exposure.
In conclusion, this study may have public health ramifications as it was shown
arsenic exposure at a level lower than the current drinking water standard maintained
pluripotency of ESC’s and reduced neural differentiation. An EMT-like mechanism may
be used to impair cellular differentiation as demonstrated by increased N-cadherin
expression. Intriguingly, the observed lack of oxidative stress leaves the possibility of
another mechanism, such as epigenetics, to be responsible for this reduced differentiation.
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Chapter One
Literature Review

Purpose of the Study
The main objective of this study was to determine how a chronic, low-level arsenic
exposure (0.1 µM) for 32 weeks impairs cellular differentiation early in development, using
P19 mouse embryonic stem cells as the model.

Routes of Arsenic Exposure
For centuries, arsenic (As) has been feared due to its harmful effects in humans,
and has often been referred to as the “king of poisons” for its use in many purposeful
poisonings (Hughes 2011). In recent times, human arsenic exposure is often through
ingestion of food and water but also through inhalation of emissions from smelting
operations and the manufacture of insecticides, pesticides, and wood preservatives
(ATSDR 2014). Human arsenic exposure has also been due to mining, as arsenic is
commonly found within metalliferous deposits of iron, manganese, and other metals of
commercial interest. These are processed, removing arsenic from the ore of interest and
leaving behind arsenic residues in mines (Camm 2004, Mandal 2002). Inorganic arsenic is
used in manufacturing, commonly for semiconductor production (Park 2010).
Furthermore, arsenic-based pesticides, predominantly lead arsenate, copper arsenate, and
calcium arsenate, have been used across the world to reduce insect damage to crops and
therefore boost agriculture production (Li 2016). A study of New Jersey farms concluded
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that between the years 1900-1980 the equivalent of 15 million lbs of arsenic was applied
to crops (Murphy 1998). As of 1986, arsenic-based pesticides were banned in the United
States (EPA 1986).
Since arsenic is found naturally in the Earth’s crust bound to metal ores such as iron
and manganese, it can enter groundwater as a result of two processes: 1) either a rise in
the pH of groundwater, leading to desorption of arsenic from mineral oxides such as iron
or manganese, or 2) as a result of the development of a strongly reducing environment
causing the desorption of arsenic from these mineral oxides and thus arsenic release into
the groundwater (Smedley 2002). A number of countries have issues with arsenic in
groundwater, including China, Mexico, Thailand, Argentina, and the United States, with
the highest incidences of exposure seen in Bangladesh and India (Dwivedi 2015) (Table
1). For example, a 1996 study demonstrated that 50% of 400 samples of groundwater from
tube wells in Bangladesh showed concentrations of arsenic greater than 50 µg/L (higher
than the WHO recommendation of 10 µg/L (WHO 2015)), while a 1997 study of the tube
wells of 200 villages showed that 62% had concentrations higher than 100 µg/L (Smith
2000, Quamruzzaman 1998). Arsenic contamination of groundwater in the United States
is also prevalent, with an estimated 2.1 million citizens obtaining drinking water from wells
with arsenic concentrations over 10 µg/L (Ayotte 2017). Naturally occurring arsenic exists
in two oxidation states, either As(III) or As (V). In the U.S., As(III) is the dominant species
in the Midwest, while both species are observed throughout the rest of the country (Sorg
2014).
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Table 1.1. Concentrations of arsenic in drinking water from various regions around the
world.
Country

Arsenic Concentration in
Drinking Water

Sources

China
Northern Mexico
Central Thailand
Central Argentina
United States (Private Wells)
Bangladesh
India (Bihar District)

Sometimes >500 µg/L
Up to 600 µg/L
Up to 100 µg/L
Up to 300 µg/L
Sometimes >300 µg/L
Sometimes >1000 µg/L
Sometimes > 1500 µg/L

He and Charlet, 2013
Fisher, et al., 2017
Kohnhorst, et al., 2002
Paoloni, et al., 2009
Neilson, et al., 2010
Flanagan, et al., 2012
Chowdhury, et al., 1999; Kumar, et al., 2016

Arsenic Ingestion
In addition to the risk from drinking water, irrigation of crops can lead to arsenic
uptake into various vegetables, grains, and fruits. For the most part, arsenic exposure
through food is a result of high consumption levels, and not high concentration levels of
the foods themselves (Gundert-Remy 2015). Exceptions to this include rice and apples,
which both readily uptake arsenic.

Rice is one of the most common food sources

worldwide with production and consumption increasing since the 1960’s (FAO 2002). A
study from 2008 compared 204 rice grain samples from around the world and concluded a
“normal” range of arsenic is 0.08-0.20 mg/kg. This same study found that mean arsenic
concentrations in rice grown in the U.S. and Europe were both 0.198 mg/kg, which was
significantly higher than rice grown in Asia (excluding rice grain from Bangladesh) with a
mean arsenic concentration of 0.07 mg/kg (Zavala 2008). Furthermore, comparing two
large data sets of arsenic levels in Bangladeshi rice, researchers showed that contaminated
irrigation water increased the arsenic concentration of rice by 0.05 to 0.13 mg/kg, or 2545% when compared to rice grown in uncontaminated environments (Zavala 2008). Apples
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are another concern (Creger 1992). Many orchard soils have high levels of arsenic due to
the previous treatment of apple trees with arsenic-based pesticides, which remain in the
soil for many years after their use (Yokel 2003, Morgan 2009). From 2005 through 2011,
the U.S. FDA monitored the amounts of arsenic found in apple juice from countries around
the world bound for U.S. markets. These studies found total arsenic concentrations ranging
from non-detectable amounts up to 45 ppb, and inorganic arsenic concentrations (the
arsenic species more harmful to human health) up to 18 ppb (FDA 2011). In 2013, the
U.S. FDA set the standard for arsenic in apple juice to the equivalent standard of arsenic
in drinking water at 10 ppb (FDA 2013).

Developmental Arsenic Exposure
Although exposure to arsenic at any age can cause negative effects, embryonic
exposure can cause deficits that may last a lifetime. Arsenic is able to pass through the
blood placental barrier and accumulate in the brain, causing toxicity during embryonic
development (Concha 1998, Jin 2006). A cohort study of the birth size of babies in
Bangladesh in 2002-2003 concluded that low levels of arsenic exposure (less than 100 µg/L
in urine) significantly reduced birth weight (Rahman 2009). Another study of 272 children
from Maine in grades 3-5 showed that children drinking water with concentrations of
arsenic higher than 5 µg/L scored lower on Full-Scale IQ tests and most Index scores
(including perceptual reasoning, working memory, and verbal comprehension) compared
to children ingesting water with lower levels of arsenic (Wasserman 2014). Furthermore,
exposure to arsenic during development increases the incidences of neonatal mortality and
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stillbirths, reduces birth weight, alters locomotor function, increases the incidence of
neurological diseases and mental retardation, and lowers intelligence quotient scores
(Hong 2012, Dakeishi 2006, Tsai 2003, Raqib 2009, von Ehrenstein 2006, Xi 2010).

Arsenic and Epidemiological Outcomes
Human exposure to arsenic causes a number of effects, most notably cancers of the
skin, bladder, kidney, lungs, and liver. A 2015 review study concluded that arsenicexposed populations showed a dose-dependent increase in skin lesions as well as basal and
squamous cell carcinomas. These trends were common in Asian countries where
populations were more likely to be exposed to drinking water with arsenic concentrations
higher than 10 µg/L (Karagas 2015). In 2014, another cohort review study concluded that
exposure to 10 µg/L arsenic in drinking water increased the risk of bladder cancer by 40%,
and the mortality rate of both bladder and kidney cancer by 30%, in populations exposed
to 150 µg/L arsenic in drinking water (Saint Jacques 2014). A meta-analyses conducted in
2014 of 12 studies concluded that long-term inorganic arsenic exposure through drinking
water increased liver cancer mortality by nearly two-fold (Wang 2014). Similar
carcinogenic findings have been observed in rodents (Tokar, et al., 2010). A study of orally
administered inorganic arsenic produced lung tumors in mice (Cui, et al., 2006), while
other studies found that oral exposure to DMAV resulted in lung tumors in mice ( Hayashi,
et al, 1998; Kinoshita, et al., 2007) and urinary bladder tumors in rats (Wei, et al., 2002;
Arnold, et al., 2006). A highly relevant study to the current project exposed CD1 mice to a
“whole-life” inorganic arsenic exposure up to 24 ppm from 2 weeks prior to breeding,
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during pregnancy, lactation, after weaning, and through adulthood up to 2 years. This study
reported dose-dependent increases in lung adenocarcinoma, hepatocellular carcinoma,
gallbladder tumors, uterine carcinomas, ovarian tumors, and adrenal tumors (Tokar, et al.,
2011).
In addition to cancer, non-carcinogenic effects such as hypertension, cardiovascular
disease, diabetes mellitus, and renal disease incidence rates are all increased in arsenicexposed populations (Patel 2010, Tchounwou 2003, Guha 2008). A 2007 study of Mexican
subjects concluded a dose-dependent increase in diabetes mellitus risk as arsenic exposure
increases (Coronado-Gonzalez 2007). A meta-analysis from 2012 concluded that there is
also a dose-dependent increase in hypertension of populations exposed to increasing
exposures of arsenic (Abhyankar 2012). Due to the detrimental effects on human health
from arsenic, in 2001 the U.S. Environmental Protection Agency lowered the drinking
water standard for arsenic in public water systems (PWS) from 50 ppb to 10 ppb, and all
PWS’s were required to be in compliance with by January 23, 2006 (EPA 2001).

Arsenic and Cellular Differentiation
While the mechanisms behind arsenic-induced reductions in growth and
neurological impairment are not fully understood, one possibility is that arsenic impairs the
ability of stem cells to differentiate. For example, one study showed that a 14-day exposure
of 10 µM sodium arsenate to human keratinocytes (SCC-9 cells) reduced expression of
involucrin, a protein crucial to keratinocyte differentiation (Kachinskas 1994, Kachinskas
1997). Another study demonstrated that pluripotent C3H 10T1/2 cells exposed to 6 µM
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sodium arsenite for two months reduced their ability to differentiate into adipocytes, as
measured by both morphology and reduced expression of the adipocyte markers aP2,
PPARγ and C/EBPα (Wauson 2002). A similar study of C3H 10T1/2 cells concluded that
short-term arsenic exposures of 3, 6, and 10 µM sodium arsenite exposures showed a dosedependent reduction in adipocyte differentiation (Trouba 2000).
In addition to reduced differentiation in keratinocytes and adipocytes, muscle and
neuronal differentiation appear to be affected by arsenic exposure. A study exposing
C2C12 mouse myoblasts to 20 nM arsenic found that the arsenic impaired differentiation,
as measured by lower levels of myogenin transcripts and reduced multi-nucleation
(Steffens 2011). In a study of muscle repair, male mice exposed to 0.5 or 5 ppm arsenic
trioxide for 8 weeks had reduced muscle regeneration following a soleus muscle injury
(Yen 2010). Arsenic exposure has also been shown to have detrimental effects on
differentiating rat PC12 neuroblasts. Frankel and colleagues showed that a 120 hour
exposure of PC12 cells to 2.5 and 5 µM sodium arsenite, decreased neurite outgrowth and
complexity in a dose-dependent manner (Frankel 2009). A study exposing Neuro-2A
neuroblastoma cells to 5 µM arsenic trioxide for 48 hours during differentiation found that
is reduced neurite outgrowth in a dose-dependent and time-dependent manner (Wang
2010). Based on these previous studies on reduced differentiation, it is postulated that
neurological and motor deficits resulting from arsenic exposure during embryogenesis can
be attributed to decreased stem cell differentiation into myotubes and neurons.
Studies from our lab are novel from others in that we use pluripotent P19 embryonic
stem (ES) cells to determine the mechanisms through which arsenic may alter
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development. One such study from 2015 showed that arsenic exposure significantly
reduced transcript and protein expression of Msx1 and Pax3, both of which are required
for neural plate border specifier cell formation (McCoy 2015). The expression of NeuroD1
transcript and protein levels required for neural crest cell differentiation, were decreased,
while Sox10 protein expression required for neural crest progenitor cell production was
also decreased. Furthermore, nuclear translocation of proteins required for myotube
formation were significantly reduced when compared to unexposed cells (McCoy 2015).

Chronic Arsenic Exposure and Resulting Formation of Cancer Stem Cells
Building on the conclusion that arsenic exposure can reduce cellular differentiation,
several studies have shown that arsenic exposed fate-determined cells can be transformed
to a cancer stem cell-like phenotype. A study of human keratinocytes (HaCaT cells)
exposed to 50 ppb arsenic for 18 weeks found that the arsenic-exposed cells formed a
multinucleated, cancer stem-like phenotype with higher rates of proliferation than passage
matched controls (Huang 2013). Similarly, exposure of human urothelial (UROtsa) cells
to a 0.05 μM concentration of the inorganic arsenic metabolite, monomethylarsenous acid
(MMAIII) for 52 weeks transformed them into malignant cells, showing anchorageindependence after 24 weeks of exposure and formation of tumors in SCID mice after 52
weeks of exposure (Bredfeldt 2006). Complementing these findings, Wnek and colleagues
determined UROtsa cells exposed to 50 nM (6.2 ppb) MMAIII experience a critical period
at 12 weeks of exposure after which UROtsa cells are irreversibly transformed into
malignant cells that formed tumors in immunocompromised mice (Wnek 2010). Further,
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at 12 weeks of arsenic exposure, DNA methylation was unchanged when compared to
control UROtsa samples; however aberrant DNA methylation was observed when these
exposed cells were cultured for 12 more weeks in untreated media (Wnek 2010). A recent
epigenetic study from 2018 exposing UROtsa cells to 50 nM MMAIII for up to 14 weeks
and found that arsenic exposure leads to increased acetylation of the H3 histone and
decreased acetylation of the H4 histone, both of which play crucial roles in chromatin
condensation and transcriptional regulation. The authors hypothesized that altered histone
acetylation was a factor in the malignant transformation of UROtsa cells following
exposure to MMAIII (Ge 2018).
While arsenic appears to phenotypically and epigenetically transform differentiated
cells to malignant cells, this alteration may be further mediated through arsenic induced
transcriptional regulation of pluripotency markers. The transcription factors Sox2 and Oct4
have been shown to increase cell “stemness” in several different cancer stem cell lineages
(CSC) by acting synergistically to maintain pluripotency and drive the transcription of
various target genes (Boumahdi 2014, Leis 2012, Hochedlinger 2005, Rodda 2005). Sox2
has been shown to work with Oct3/4 to activate Oct-Sox enhancers, which in turn regulate
the expression of Nanog, Oct3/4, and Sox2 itself (Masui 2007). Not only will Sox2 act
synergistically with Oct3/4, but Sox2 can also regulate several transcription factors that
control the expression of Oct3/4. Meanwhile, the forced expression of Oct3/4 will rescue
the pluripotency of Sox2-null ES cells, lending credence to the idea that Sox2 helps
maintain ES cells in a pluripotent state through ensuring the proper expression of Oct3/4
(Masui 2007). A chronic exposure of immortalized human urothelial cells (HUC1) to 1.0
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µM arsenic trioxide for 12 months led to increased expression of Sox2, Oct4, and Nanog
transcript and protein levels. Of particular interest, Sox2 was shown to be overexpressed
gradually and irreversibly. Researchers then knocked-down Sox2 expression in these
arsenic treated HUC1 cells leading to decreases in expression of Oct4, Nanog, CD133, and
CD24, as well as a reduction in stem-like properties including invasion and
chemoresistance (Ooki 2018).
Further, human bronchial epithelial (HBE) cells exposed to 1.0 µM arsenite for 15
weeks began to show significant increases in Oct4 transcript expression by week 5 of the
exposure, as well as increases in Bmi1 and ALDH1 transcripts. This same study observed
no significant increases in Sox2 or Notch1 expression (Xu 2012). A study of a different
human bronchial epithelial cell line (BEAS-2B) exposed to 0.25 µM arsenite for 6 months
reported increases in the expression of Klf4, Myc, Oct4, and Sox2 transcript and protein
expression in the arsenic transformed cells (Chang 2014). Another chronic in vitro study
exposed human epithelial stem/progenitor cells (WPE-stem) to 5 µM arsenite for 18 weeks.
Interestingly, it was observed that several markers of self-renewal, including Bmi1,
Notch1, and Oct4, were decreased for the first several weeks of the arsenic exposure, but
all markers began to increase later. This pattern of expression was inversely related to the
expression of PTEN, a tumor suppressor gene, leading the authors to conclude that arsenic
exposure inhibits PTEN expression, resulting in the eventual increase of self-renewal
marker expression and the formation of CSC-like cells (Tokar 2010). Collectively, these
studies show that chronic arsenic exposure may induce cancer stem cell transformation by
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increasing levels of pluripotency and self-renewal markers, while simultaneously reducing
the expression of tumor suppressor genes.

Arsenic and Epithelial-Mesenchymal Transitions
Epithelial-mesenchymal transition (EMT) is a process in which immotile, polarized
epithelial cells transform into motile, mesenchymal cells (Yang 2008). Specifically,
mesoderm and neural crest formation result from EMT during embryogenesis, with the
resulting cells maintaining their oliogopotentiality and ability to further differentiate (Yang
2008). In addition, the transformation into a mesenchymal phenotype facilitates the
metastasis of cells from primary carcinomas (Thiery 2002). Immortalized human
mammary epithelial cells (HMLEs) induced to go through EMT will acquire mesenchymal
traits, express stem-cell markers more efficiently formed mammospheres, colonies in soft
agar, and tumors (Mani 2008). A family of transmembrane glycoproteins known as
cadherins play a key role in the maintenance of the organized structures of solid tissue. Of
these cell-to-cell adhesion molecules, E-cadherin, N-cadherin, and P-cadherin are the most
commonly studied (Gumbiner 1996). It is widely known that E-cadherin expression is
inversely related to N-cadherin expression in aggressive tumors undergoing EMT, leading
to increased tumor invasiveness and metastasis (Tran 1999, Christiansen 2006, Kang
2004). A study of human prostate tumors revealed that “cadherin switching,” resulting in
EMT through decreased E-cadherin expression and increased N-cadherin expression, was
associated with cancer progression as well as cancer-specific death (Gravdal 2007).
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Following these trends, a previously mentioned study of human bronchial epithelial
(HBE) cells exposed to 1.0 µM arsenite for 15 weeks resulted in increased N-cadherin
transcript and protein expression beginning at 5 weeks of exposure while E-cadherin
expression was inversely decreased. Vimentin expression, another marker of EMT
progression, was also shown to increase beginning at week 5 of arsenic exposure (Xu
2012). Immortalized human urothelial cells (HUC1) exposed to 1.0 µM arsenic trioxide
for 12 months showed similar results, with N-cadherin and vimentin expression increasing
in arsenic-transformed cells while E-cadherin decreased (Ooki 2018).
While EMT is driven by cadherins, many studies have implicated the Wnt/ βcatenin signaling pathway as the mechanism by which cadherins are regulated (Xu 2015).
Cho and colleagues studied the role of CD44 in SW480 colon cancer cells and reported
that EMT increased in cells overexpressing CD44 and decreased in CD44 knockdown cells.
This may be attributed to the fact that CD44 is the transmembrane adhesion receptor for
hyaluronic acid (HA). As the receptor for HA, CD44 is responsible for the degradation of
HA, which can result in cell migration, cancer invasion, and metastasis (Ponta 2003,
Nagano 2004, Rodgers 2006). It was shown that increased CD44 expression led to
upregulation of N-cadherin expression, and the downregulation of E-cadherin expression.
Additionally, β-catenin was shown to translocate to the nucleus of cells, resulting in
transcription of EMT-inducing genes. This inhibited formation of the E-cadherin-β-catenin
complex, and resulted in cell migration and invasion (Cho 2012). Further, the Wnt/ βcatenin target gene, L1CAM (L1), is known to induce stemness in cancer cells (Beck 2015).
The L1 gene is capable of inducing nuclear translocation of β-catenin and decreasing E-
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cadherin expression in both mammary epithelial cells as well as colorectal cancer cells
(Shtutman 2006, Basu 2018). Previous studies from our lab show that P19 embryonic stem
cells exposed to arsenic have repressed levels of β-catenin transcripts, while inversely
showing increases of the Nanog gene, a marker of pluripotency, suggesting that arsenic
exposure delays differentiation through increased pluripotency (Hong 2012).

Hypothesis and Aims
Thus, our hypothesis of the current study is that chronic, low-dose arsenic
exposure delays differentiation and increases pluripotency of embryonic stem cells
through the activation of an EMT-like mechanism.
Aim 1: Determine if a 32-week chronic arsenic exposure alters the differentiation of
P19 stem cells
P19 mouse embryonic stem cells (ESC’s) were exposed to 0 or 0.1 µM (7.5 ppb)
sodium arsenite, a concentration lower than the current drinking water standard, for 32
weeks. Cells were sampled every 4 weeks for a total of 8 sampling periods. At each of
these sampling points, ESC’s were differentiated for a total of 9 days, first into embryoid
bodies and then adult cells, through the hanging drop method. The goal of this aim was to
develop a time course and determine whether exposure of stem cells to arsenic at levels
below the current drinking water standard would impair their ability to differentiate.
To assess changes in differentiation over the 32-week period, embryoid bodies were
imaged at day 9 of each sampling period to provide a subjective comparison of
morphological changes. A profiler array was utilized to assess differential expression of a
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suite of genes involved in cell-fate determination. Next, using the profiler array data,
expression of select genes involved in cellular differentiation including Dcx, MyoD, and
NeuroD, and the pluripotency markers Nanog, Sox2, Oct4, were quantified by qPCR. To
further

validate

differential

expression

of

pluripotency

marker

mRNA,

immunohistochemistry (IHC) and immunoblotting were used to quantify protein
expression of the pluripotency-associated transcription factor, Sox2.
Based on previous studies, it was expected that genes and proteins involved in
differentiation would be down-regulated, and genes involved with pluripotency would be
up-regulated in the arsenic-exposed samples by around week 24 of the exposure.
Aim 2: Determine mechanism through which arsenic impairs differentiation and
maintains pluripotency of P19 stem cells

The expression of oxidative stress markers, Hmox1 and Nrf2, were analyzed by
qPCR as it could be expected arsenic may impair differentiation through an oxidative stress
mechanism. Furthermore, a process known as an epithelial-mesenchymal transition (EMT)
is known to play a role in pluripotency induction. Therefore, IHC was used to quantify the
expression of E- and N-cadherin, cell-to-cell adhesions molecules involved in EMT. It was
predicted that expression of the mesenchymal marker, N-cadherin, would increase with the
induction of pluripotency, while expression of the epithelial marker, E-cadherin, would be
subsequently decreased.
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Abstract
Arsenic is a contaminant found in many foods and drinking water. Exposure to
arsenic during the embryonic and fetal stages of development is known to decrease birth
weight, stunt weight gain, and result in improper neuronal development and function.
Previous in vitro studies that exposed progenitor cells, such as C2C12 myoblasts and
Neuro-2A neuroblastoma cells, have reported that arsenic reduced their differentiation into
myotubes and neuroblasts, respectively. This study exposed P19 mouse embryonic stem
cells continuously to 0.1 μM (7.5 ppb) arsenic for 32 weeks, with the aim of delineating
how chronic arsenic exposure impacts cellular differentiation during development. A cell
lineage profiler array examining mRNA changes after 8 and 32 weeks of exposure showed
that genes involved in pluripotency were increased, while those involved in differentiation
were reduced. The temporal impairment of cellular differentiation was investigated by
mRNA analysis of select pluripotency and neuronal differentiation markers throughout the
32 week exposure. The results show that Sox2 and Oct4 mRNA expression was increased
by 1.4- to 1.8-fold in the arsenic-exposed cells, beginning at week 8. Compounding this,
Sox2 protein expression was increased by 1.4-fold, starting at week 16. A prevailing
hallmark of epithelial-mesenchymal transitions (EMT) is increased expression of the cellto-cell adhesion molecule N-cadherin, which is known to be induced by Sox2. Exposure to
arsenic resulted in significantly increased N-cadherin protein levels of 1.3-fold beginning
at week 20 and continuing through week 32 of exposure, concurrent with increased
grouping of N-cadherin positive cells at the perimeter of the embryoid body. Taken
together, these results support that a chronic, low-level arsenic exposure during

31

development may delay neuronal differentiation and maintain pluripotency through an
EMT-like mechanism.
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1. Introduction
Arsenic (As) is a ubiquitous groundwater toxicant found throughout the world,
including countries such as China, Mexico, and the United States, with the highest
incidences of exposure seen in Bangladesh and India (Dwivedi 2015). Many people in
these countries are exposed to arsenic concentrations higher than the World Health
Organization (WHO) recommendation and U.S. Environmental Protection Agency (U.S.
EPA) standard of 10 ppb in drinking water (EPA 2001, WHO 2015). In addition to the risk
from drinking water, various vegetables, grains, and fruits are known to readily uptake
arsenic. Specifically, rice and apples uptake arsenic from irrigation water and soil (Zavala
2008, Creger 1992, Yokel 2003, Morgan 2009). In adults, chronic arsenic exposure has
been correlated with cancers of the skin, bladder, liver, lungs, and kidneys, as well as noncarcinogenic conditions including hypertension, diabetes mellitus, and cardiovascular
disease (Tchounwou 2003, Guha 2008). Although exposure to arsenic at any age could
cause negative health outcomes, embryonic arsenic exposure can cause deficits that may
last a lifetime. Arsenic is able to cross the blood placental barrier of pregnant women,
acting as a developmental toxicant and resulting in similar arsenic concentrations in both
cord and maternal blood (Concha 1998). Consequently, epidemiological studies report
increased incidences of stillbirths, reduced birth weight and weight gain (Concha 1998,
Raqib 2009, von Ehrenstein 2006), altered locomotor activity, and learning deficits
(Dakeishi 2006, Tsai 2003) in locations with high concentrations of arsenic in drinking
water. Further, children subjected to arsenic exposures in excess of the 10 ppb standard,
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show deficits in full-scale IQ, verbal IQ, and memory compared to their unexposed
counterparts (Tolins 2014).
In order to delineate the mechanisms through which arsenic induces these
developmental deficiencies, studies of rats have shown that arsenic is able to cross the
blood brain barrier (Xi 2010). Investigators have shown that PC12 rat neuroblast cells
acutely exposed to 5 µM and 10 µM arsenic had reduced neurite length and less branching
compared to control samples (Frankel 2009). Another study exposed Neuro-2A mouse
neuroblastoma cells to 5 µM arsenic trioxide for 48 hours during differentiation, resulting
in reduced neurite outgrowth in a dose- and time-dependent manner (Wang 2010). In
addition to neurodevelopmental deficits, arsenic also acts to hinder muscle development
and repair. A study of mice exposed to 100 µg/l sodium arsenite in drinking water for 5
weeks concluded that arsenic exposure impairs muscle regeneration and the recovery of
muscle function following cardiotoxin injury to the tibialis anterior (Zhang 2016).
Similarly, a study of mice exposed to 0.5 and 5 ppm arsenic trioxide for 8 weeks in drinking
water resulted in decreased myogenin expression, a reduction in myofibers, and an increase
in collagen levels of arsenic exposed mice after induced necrotic injury the soleus muscle.
An in-vitro component of this same study reported decreased differentiation of C2C12
mouse myoblasts after 4 days of 0.1-0.5 µM arsenic trioxide exposure (Yen 2010). Another
study of C2C12 mouse myoblasts also described reduced differentiation, validated by
decreased myogenin transcript level and reduced multi-nucleation following an exposure
of 20 nM arsenic during 4 days of differentiation (Steffens 2011). Previous studies of P19
mouse embryonic stem (ES) cells from our lab have shown a reduction in both skeletal
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myotube and neuron formation, but not proliferation, following a 0.5 µM sodium arsenite
exposure (Hong 2012).
While these previous studies have shown that acute, in vitro arsenic exposure can
reduce cellular differentiation, several studies have also shown that fate-determined cells
chronically exposed to arsenic can be transformed to a cancer stem-cell phenotype. A study
of human keratinocytes (HaCaT cells) exposed to 50 ppb arsenic for 18 weeks found that
the exposed cells developed a cancer stem-like phenotype that showed higher rates of
proliferation when compared to passage matched controls (Huang 2013). Similarly,
exposure of human urothelial (UROtsa) cells to a 0.05 μM (6.2 ppb) concentration of the
inorganic arsenic metabolite, monomethylarsenous acid (MMAIII) for 52 weeks
transformed them into malignant cells, showing anchorage-independence after 24 weeks
of exposure and the formation of tumors in SCID mice after 52 weeks of exposure
(Bredfeldt 2006). Compounding these findings, Wnek and colleagues determined that
UROtsa cells exposed to 50 nM (6.2 ppb) MMAIII experience a critical period at 12 weeks
of exposure after which UROtsa cells are irreversibly transformed into malignant cells
(Wnek 2010).
While arsenic appears able to transform differentiated cells to malignant cells, this
alteration may be mediated through arsenic induced transcriptional regulation of
pluripotency markers. The transcription factors Sox2 and Oct4 have been implicated in
several different cancer stem cell lineages (CSC), increasing cell “stemness” by acting
synergistically to maintain pluripotency and drive the transcription of various target genes
(Boumahdi 2014, Leis 2012, Hochedlinger 2005, Rodda 2005). Sox2 has been shown to
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work with Oct3/4 to activate Oct-Sox enhancers, which in turn regulate the expression of
Nanog, Oct3/4, and Sox2 itself (Masui 2007). Not only will Sox2 act synergistically with
Oct3/4, but Sox2 can also regulate several transcription factors which control the
expression of Oct3/4. Meanwhile, the forced expression of Oct3/4 will rescue the
pluripotency of Sox2-null ES cells, lending credence to the idea that Sox2 helps maintain
ES cells in a pluripotent state through ensuring the proper expression of Oct3/4 (Masui
2007). A study of human bronchial epithelial (HBE) cells exposed to 1.0 µM arsenite for
15 weeks began to show significant increases in Oct4 transcript expression by week 5 of
the exposure, while no significant increases in Sox2 or Notch1 expression were observed
(Xu 2012). Another chronic in vitro study exposed human epithelial stem/progenitor cells
(WPE-stem) to 5 µM arsenite for 18 weeks. Interestingly, it was shown that several markers
of self-renewal, including Bmi1, Notch1, and Oct4, were decreased for the first several
weeks of the arsenic exposure, before all markers began to increase later. This pattern of
expression was inversely related to the expression of PTEN, a tumor suppressor gene,
leading the authors to conclude that arsenic exposure inhibits PTEN expression, resulting
in the eventual increase of self-renewal marker expression and the formation of CSC-like
cells (Tokar 2010).
The purpose of the current study was to examine whether long-term arsenic
exposure, below the current drinking standard of 10 ppb, altered the differentiation of P19
stem cells into neurons and myotubes, and if so, investigate the mechanisms responsible.
Our results demonstrate that arsenic exposure after 8 weeks increases Sox2/Oct4 transcript
expression, while decreasing doublecortin expression by 12 weeks of exposure, indicating
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reduced neuronal differentiation. Further, at approximately 16 weeks of exposure, we
report an overall increase in N-cadherin protein expression, as well as increased groupings
of N-cadherin positive cells at the perimeter of arsenic exposed embryoid bodies. These
results suggest that chronic arsenic exposure hinders the ability of neural progenitor cells
to properly differentiate.

2. Methods

2.1 P19 Cell Culture
P19 mouse embryonic stem cells were obtained from Sigma-Aldrich (St. Louis,
MO, USA).

These are pluripotent embryonal carcinoma cells derived from a

teratocarcinoma (McBurney 1993). Cells were cultured in α-MEM media containing 7.5%
bovine calf serum, 2.5% fetal bovine serum, and 0.1% L-glutamine. Cells were cultured in
control medium or medium containing 0.1 µM arsenic as sodium arsenite, equivalent to
7.5 ppb arsenic, for up to 32 weeks. This arsenic concentration is lower than the 10 ppb
drinking water standard set by the EPA and WHO. Both the control and the arsenic
exposed samples were cultured as three independent replicates (n=3 for each treatment).
The cells were cultured in a humidified incubator at 37oC and 5% C02, and passaged every
two to three days to maintain low confluency and avoid premature cellular differentiation.
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2.2 P19 Cell Differentiation
At eight time points (once every four weeks of the 32-week exposure), the six
separate cultures of cells (n=3 for each treatment) were differentiated in 1% DMSO media
via the hanging drop method (500 cells/drop) (Wang 2008). After two days, individual
embryoid bodies were transferred to 96-well ultralow attachment plates for another three
days. Representative images of day 5 embryoid bodies were captured using a VWR
VistaVision microscope camera. After imaging, embryoid bodies from one 96-well plate
were pooled together, washed in PBS, and placed in 10% neutral buffered formalin
overnight at 4oC for immunohistochemistry analyses. A second 96-well plate was collected
for RNA extraction and stored in Trizol (Thermo Fisher, Waltham, MA) at -80oC, and a
third 96-well plate of day 5 embryoid bodies was collected and stored in RIPA buffer
(Thermo Fisher) at -80oC for immunoblot analysis. An additional set of day 5 embryoid
bodies were transferred to 0.1% gelatin-coated 48-well plates, and medium was refreshed
every other day. On day 9, representative pictures were taken. Afterwards, half of the day
9 cells were collected and stored in Trizol at -80oC for RNA extraction, while the other half
were collected and stored in RIPA lysis buffer at -80oC for protein extraction.

2.3 Cell Lineage Profiler Array
To initially assess changes over the continuous 32-week exposure, RNA from day
9 control and arsenic-exposed P19 cells from two selected time points were analyzed using
a Qiagen RT2 Profiler Cell Lineage PCR Profiler Array (Germantown, Maryland). This
array detects expression of a suite of 84 genes involved in cellular differentiation. Briefly,
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RNA from week 8 and week 32 cells at day 9 of differentiation was extracted using Trizol,
and RNA concentration and purity were determined on a Nanodrop (Thermo Scientific,
Waltham, MA). A Qiagen RT2 First Strand Kit was used to synthesize cDNA from 2 µg
of pooled RNA from control and arsenic-exposed treatments, respectively (n=3-4).
Quantitative PCR was then conducted with SYBR Green PCR Master Mix (Applied
Biosystems). Array data was analyzed using Qiagen GeneGlobe Data Analysis Center
(https://geneglobe.qiagen.com/us/analyze/).

2.4 Gene expression analysis using Quantitative PCR

RNA was extracted using Trizol, and RNA concentration and purity were
determined on a Nanodrop (Thermo Scientific, Waltham, MA) and stored at -80oC.
Reverse transcription was conducted at 37oC using 2 µg RNA, 10mM deoxynucleotide
mix, 50 ng/µL random hexamers, and 1U murine moloney leukemia virus reverse
transcriptase (MMLV-RT). Gene expression was determined by quantitative PCR (qPCR)
on an Applied Biosystems StepOnePlus Real-Time PCR system (Foster City, CA, USA).
qPCR was performed using SYBR Green PCR Master Mix (Applied Biosystems), 40ng
cDNA, and 10 µM forward and reverse primers for genes of interest (Table 1). All samples
were run in triplicate and melt curves were used to verify gene specific binding. PCR
efficiency and linearity were determined using a standard curve generated by serial
dilutions of five concentration points (10-3 to 10 -7 ng DNA) of the gene of interest. Gapdh
was used as a housekeeping gene, as we have shown previously that its expression does
not vary due to arsenic exposure (Liu 2018). Relative fold expression compared to the
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controls was quantified by the Delta-Delta Ct method (Schmittgen 2008). Statistical
significance of differential gene expression was determined by comparing the average
2^ddCt results of the control and arsenic exposed replicates using Student’s t-test (p ≤ 0.05)
(n=3-4).

2.5 Determining Protein Expression by Immunohistochemistry

After an overnight fixation, day 5 embryoid bodies were dehydrated, embedded in
paraffin, and sectioned at 5 µm. Slides were deparaffinized and antigen retrieval was
carried out in Tris-EDTA buffer (pH 9). Primary antibodies for Sox2 (1:2000, Abcam,
#ab97959), N-cadherin (1:250, Santa Cruz, #sc-59987), and E-cadherin (1:250, Novus,
#NBP2-19051) were incubated overnight at 4oC. Following incubation with Alexa Flour
488 secondary antibodies (1:1000, anti-rabbit, #A11034 and 1:500, anti-mouse, #A11001);
Life Technologies), nuclei were counterstained with DAPI (Invitrogen). All samples were
imaged on a Leica SPE Confocal microscope (Wetzlar, Germany) equipped with
traditional PMT detectors and a 20x objective. Excitation wavelength for all antibodies was
488 nm with emission wavelength between 500-560 nm, while the excitation wavelength
for DAPI was 405 nm with an emission wavelength of 430-480 nm. Imaging parameters
(laser power, gain, and offset) for each antibody were held consistent between control and
arsenic-exposed groups at each individual time point for each antibody. Thus, statistical
significance was determined by comparing control and arsenic-exposed cells of the same
time point. Images were analyzed in ImageJ to determine any differences in protein
expression (pixel intensity) (Tenbaum 2012).
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Sox2 expression was determined by

counting the number of cells using the particle analyzer function, and then dividing the
integrated density by cell count to get an integrated density value (IDV) per cell. This
analysis was done to account for differences in embryoid body sizes. Since N-cadherin
was predominantly expressed at the peripheral boundaries of embryoid bodies, protein
expression in ~5 cells of the outer border only were included in the analysis. The outer
edge of the embryoid body and an inner ring were traced, and fluorescence within these
borders was analyzed. This reduced variability due to non-uniform embryoid body size
and/or size of the N-cadherin negative cell mass within embryoid bodies. Using this
measurement, an IDV value could be determined. Expression of E-cadherin was more
evenly spread though embryoid bodies, therefore expression was analyzed by the IDV of
each embryoid body. All data were averaged for each treatment group, and statistical
differences between the control and arsenic exposed replicates of each time point were
determined using Student’s t-test (p ≤ 0.05) (n=3-4).

2.6 Analyzing Sox2 Expression by Immunoblotting

Cells were exposed to 0 or 0.1 µM arsenic, collected at day 5 and day 9 of
differentiation, and stored in RIPA lysis buffer (Thermo Fisher) at -80 oC. Day 5 and 9
cells were lysed in RIPA buffer containing protease and phosphatase inhibitors (Thermo
Fisher), and then centrifuged at 12,000 g for 20 minutes. Protein concentration of the
supernatants was determined using a BCA protein assay kit (Thermo Scientific), with BSA
as a standard. Proteins (10 µg) were electrophoresed onto 5-20% TBX gels (Bio-Rad,
Hercules, CA). Immunoblotting was performed according to standard methods, using
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primary antibody for Sox2 (1:1000, Abcam, #ab97959). Secondary antibody and dilution
was goat anti-rabbit-HRP (1:2000, Santa Cruz, #sc-2004). Protein expression was
examined by chemiluminescence (Luminol, Santa Cruz) on a Bio-Rad ChemiDoc imaging
system. Densitometry values were determined using ImageJ software and normalized to
Gapdh (1:1000, GeneTex, #GTX627408) as a loading control. Densitometry values for
each treatment were averaged and statistical differences between the control and arsenic
exposed replicates were determined using Student’s t-test (p ≤ 0.05) (n=3-4).

3. Results

3.1 Chronic, low-level arsenic exposure impairs cellular differentiation
The overarching goal of this study was to assess the impacts of long-term, lowlevel arsenic exposure on cellular differentiation. Thus, P19 mouse embryonic stem cells
were chronically exposed to 0.1 µM (7.5 ppb) arsenic for up to 32 weeks. Every four weeks,
a portion of the cells were differentiated via hanging drops and DMSO treatment (Wang
2008), and their development into embryoid bodies (EBs) after 5 days (D5) and then
terminally differentiated cells after 9 days (D9) was examined. Images taken of day 9
embryoid bodies (Figure 1) indicate that there does not appear to be any morphological
differences between the control and arsenic-exposed cells at any of the time points
examined, as both are differentiating into elongated myoblasts and neuroblasts.
To better understand if a low-level, chronic arsenic exposure resulted in impairment
of cellular differentiation, mRNA levels of a suite of 84 genes were examined using a
mouse cell lineage PCR array. Analysis of differential gene expression in the week 8 and
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week 32 cells indicates that transcript levels of genes involved in maintaining pluripotency,
including Sox2 and Oct4 were upregulated in the arsenic-exposed cells (Table 2).
Similarly, transcripts of ectodermal and neuroectodermal germ cells were increased in the
arsenic-exposed cells. These genes included Fgf5, Forkhead box D3 (FoxD3), zinc finger
protein of the cerebellum 1 (Zic1), and gastrulation brain homeobox 2 (Gbx2). However,
genes that were indicative of more differentiated neurons, including doublecortin (Dcx)
and prominin 1 (Prom1), were both decreased in the arsenic exposed cells (Table 2). Genes
involved in mesoderm formation, such as brachyury (Tbxt) and Gata2 were either
downregulated or not changed, while those involved in terminal skeletal muscle
differentiation were reduced (Table 2). Genes involved in endoderm formation were either
not expressed or were expressed at low levels, but not different between the groups (data
not shown).
Using this data, expression of select differentially-expressed genes were examined
in P19 cells exposed acutely (9 days) to 0.5 µM arsenic, to ensure the responses were due
to arsenic exposure, rather than long-term culture. Transcripts required for the maintenance
of pluripotency, such as Sox2 and Oct4 (Takahashi 2006) were examined, along with
markers for neuronal progenitors and immature neurons, including Gad2 and doublecortin
(Patel 2006, Francis 1999). In the 0.5 µM arsenic-exposed cells, Sox2 and Oct4 expression
remained unchanged, while Gad2 expression decreased by 2.5-fold and doublecortin
expression decreased by 5-fold (Figure 2).
Next, differentiation expression changes in the chronically-exposed cells was
examined. Since both Sox2 and Oct4 transcription factors are involved in pluripotency
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maintenance, and each protein can bind to and feedback on the others promoter to enhance
gene expression (Rodda 2005, Masui 2007), the expression of Oct4 and Sox2 were
averaged. At week 0, there are no differences in Sox2/Oct4 expression. However, their
expression gradually increased in the cells chronically exposed to 0.1µM arsenic such that
at week 8, they were 1.7-fold higher than in the control cells (Figure 3). Similarly, in weeks
12 and 20, Sox2/Oct4 expression was still significantly increased by 1.6-fold and 1.4-fold,
respectively (Figure 3). While no statistical differences were seen between the week 24
samples, relative levels in the exposed cells were increased by ~1.5 fold (Figure 3).
In contrast, transcript levels of doublecortin (Dcx) were reduced between weeks 8
and 24 (Figure 4). The doublecortin gene is highly expressed in the developing brain,
specifically in migrating neurons (Francis 1999). While Dcx expression was consistently
reduced during the chronic exposure, this reduction was only statistically significant at
week 12 and week 20 with fold changes of 1.3- and 1.4 -fold, respectively (Figure 4).
Taken together, these results suggest that chronic, low-level arsenic exposure represses
neural differentiation and allow cells to remain in a more pluripotent state

3.2 Arsenic exposure increases the expression of Sox2 and N-cadherin over time
To confirm changes in pluripotency, Sox2 protein expression was examined by
immunohistochemistry at weeks 0, 8, 16, 20, and 28. While some Sox2 was present in the
cytoplasm, the majority was observed to be in the nucleus of individual cells (Figure 5A).
No differences in Sox2 expression were seen between control and arsenic-exposed cells at
week 0 or week 8 (Figure 5A). However, overall Sox2 expression was increased by week
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16 and remained elevated in cells chronically exposed to arsenic. Image quantification
showed that arsenic-exposed cells had increased expression of Sox2 by 1.4-fold at week
16 and by week 28, the expression level had increased even further to 2.1-fold higher than
controls (Figure 5B).
Previous studies have described a feedback loop between Sox2 overexpression and
the induction of epithelial-mesenchymal transitions (EMT), possibly leading to cellular
dedifferentiation (Yang 2014, Herreros-Vilanueva 2013). To examine a possible EMT-like
mechanism of maintained pluripotency, the EMT marker N-cadherin, was investigated by
immunohistochemistry. Subsequent image analysis indicated that chronic arsenic exposure
results in a temporal increase in the expression of N-cadherin (Figure 6A). In addition, Ncadherin positive cells clustered together at the periphery of embryoid bodies,
demonstrating arsenic-induced protein patterning changes.

While there were no

differences in N-cadherin expression early in the exposure, arsenic-exposed cells at weeks
20 and 28 showed significant increases in N-cadherin levels (Figure 6B). The expression
of E-cadherin was also examined, however in the current study it was shown that Ecadherin protein expression remained unchanged through the exposure (Figure 6C-5D).

4. Discussion
The results demonstrate that a chronic, environmentally-relevant arsenic exposure
hinders cellular differentiation and maintains stemness through the induction of markers
commonly indicative of epithelial-mesenchymal transition (EMT). This increased
pluripotency appears to result in decreased neural differentiation.
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4.1 Arsenic maintains pluripotency of neural stem cells
To investigate arsenic-impaired differentiation, the pluripotency-associated
transcription factors, Nanog, Sox2, and Oct4, were assessed. A known positive feedback
loop exists between Sox2 and Oct4, whose expression is directly tied to increased
pluripotency (Rodda 2005, Masui 2007). Though well-known to play a role in the general
pluripotency maintenance of totipotent cells, Sox2 is also commonly expressed in
multipotent lineages including embryonic neural stem cells (Ferri 2004). Combined Sox2
and Oct4 transcript levels were consistently elevated in embryonic stem cells chronically
exposed to arsenic, with a significant increase of 1.7-fold first observed at week 8 of
exposure. Protein expression changes of Sox2 observed by immunohistochemistry and
immunoblotting

were

much

more

pronounced.

Sox2

levels

assessed

by

immunohistochemistry began to be up-regulated later than Sox2/Oct4 mRNA, with
increases of 1.5- and 2.1-fold in arsenic treated samples at week 20 and week 28 of
exposure, respectively. It was also noted that Sox2 remained localized in the nuclei of cells,
with minimal translocation. Increased expression of Sox2 protein levels by immunoblot of
10-fold at week 20 and 15-fold at week 24 compound these findings. Robust and
consistently increased Sox2 protein expression, paired with temporally variable expression
of Sox2/Oct4 mRNA, suggest that arsenic may be acting upon a possible epigenetic
mechanism to maintain pluripotency in stem cells. Meanwhile, Nanog expression was not
consistently altered throughout the chronic 0.1 µM arsenic exposure (data not shown).
Similarly, a previous acute study of 0.1, 0.5, and 1 µM arsenic on P19 stem cells resulted
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in significantly increased mRNA expression of Nanog at the 0.5 and 1 µM arsenic
concentrations, but not at 0.1 µM (Hong 2012).
Several previous studies have implicated arsenic exposure in the induction of Sox2
and Oct4. A chronic exposure of 0.25 µM arsenic for six months reprogrammed human
bronchial epithelial cells (BEAS-2B) into cancer stem cells (CSC’s) that exhibited elevated
Sox2 and Oct4 expression levels, while a study of human urothelial cells (HUC1)
chronically exposed to 1 µM arsenic trioxide for up to 12 months attained malignant
properties which included increased Sox2 expression, self-renewal, invasion, and
chemoresistance (Chang 2014, Ooki 2018). It is not being proposed that the current study
resulted in the formation of CSC’s, however these previous studies do show differential
expression of Sox2 and Oct4 similar to that observed in this chronic exposure and
consistent with arsenic-induced pluripotency.
In order to determine possible downstream consequences of maintained
pluripotency, the expression of several early neural markers were investigated. Previous
studies from our lab have shown a reduction of transcription factors involved in neural
differentiation, including neurogenin, Ascl1, and NeuroD1 following a 0.5 µM arsenic
exposure (Hong 2012, Liu 2014, Liu 2018). However, being that these markers were not
altered at the 0.1 µM concentration, several new genes of interest were examined. These
included Gad2, a gene associated with synaptic vesicles and GABA production; and
doublecortin (DCX), a marker of immature neurons often expressed during developmental
neuronal migration (Patel 2006, Francis 1999). Expression of Gad2 was observed to be
decreased by 2-fold in an acute 0.5 µM exposure and down-regulated at both week 8 and
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week 32 of the chronic, 0.1 µM exposure. Further, a significant 5-fold decrease in
doublecortin mRNA was observed in the acute 0.5 µM exposure, while expression was
consistently reduced throughout the chronic, 32-week, 0.1 µM exposure with statistically
significant decreases of ~1.3- and ~1.4 -fold at weeks 12 and 20, respectively. These
findings were congruent with a study that reported doublecortin (DCX) expression to be
decreased in mice exposed to 50 ppb arsenic during perinatal development (Tyler 2013).
Overall, the current study demonstrates that Sox2 and Oct4 expression increased
over time in arsenic-exposed cells, concomitant with a reduction in Gad2 and doublecortin
expression. These results suggest that neural pluripotency is maintained in embryonic stem
cells following chronic arsenic exposure.

4.2 Arsenic alters N-cadherin protein expression and patterning within embryoid
bodies
During proper embryonic development, the expression of a family of cell-to-cell
adhesion molecules known as cadherins, are highly regulated. In particular, epithelial and
neural cadherins (E- and N-cadherin, respectively) have been implicated in developmental
EMT and consequently regulate embryonic gastrulation and neurulation (Stemmler 2008,
Brayshaw 2016). Following chronic arsenic exposure, the expression of N-cadherin and Ecadherin were assessed by immunofluorescence. It was shown that N-cadherin protein
expression was first increased in the arsenic-treated samples at week 20 by 1.3-fold. Being
that N-cadherin is a cell-cell adhesion molecule, the N-cadherin antibody was
predominantly expressed at the periphery of embryoid bodies of both control and arsenic-
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exposed samples as they expanded and grew. Further, it was observed that N-cadherin
positive cells of the arsenic-treated samples clustered together, resulting in altered
patterning which was less pronounced in control samples.
Interestingly, it has been reported that N-cadherin is required for the maintenance
of neural precursors in the ventricular zone of the developing cerebral cortex, with
decreases in expression resulting in premature neural differentiation and increased cellular
migration from the ventricular zone (Zhang 2010). Increased N-cadherin expression and
grouping in the arsenic-exposed cells could be indicative of maintained stemness and
delayed differentiation of neural progenitor cells. A recent study of lead (Pb) toxicity in
P19 cells reported that exposures of 1-3 µM increased Sox2 expression while N-cadherin
levels were reduced, which corresponded with decreased neuronal and glial differentiation
(Mansel 2019). While the current arsenic exposure also observed increased Sox2
expression, the increased expression of N-cadherin contradicts the study of lead exposure.
However, this could be explained by the possibility of the formation of different neural
stem cell populations in each study. It has been shown that N-cadherin is expressed in
neuroblasts and neuroblast transit-amplifying cells, while down-regulation of N-cadherin
promotes glial cell differentiation (Yagita 2009). In the current study, arsenic may be acting
to maintain neuroblast and neuroblast transit-amplifying lineages, at the cost of glial
differentiation.
Typically, there is an inverse relationship in the expression of N-cadherin and Ecadherin during EMT due to a process known as cadherin switching. During cadherin
switching, expression of the epithelial-associated E-cadherin is reduced, while expression
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of the mesenchymal-associated N-cadherin is increased, leading to the promotion of
cellular motility and invasion. This process is reversible and known to play a crucial role
in proper embryonic development as well as cancer formation (Stemmler 2008, Brayshaw
2016, Maeda 2005). Interestingly, throughout the chronic arsenic exposure, as N-cadherin
expression was temporally increased, E-cadherin levels remained static.
Of the common EMT markers, it is known that N-cadherin in particular may be
regulated via Sox2, as N-cadherin expression is thought to be governed by several Soxdependent enhancers (Matsumata 2005). Beyond its required role in the formation of a
pluripotent inner cell mass early in development, it has been widely shown that Sox2 is
involved in the induction of EMT, as well as stem cell and cancer stem cell maintenance
and proliferation (Avilion 2003, Herreros-Villanueva 2013, Novak 2019, Weina 2014). It
has been shown that Sox2 overexpression promotes an EMT phenotype in laryngeal cancer
Hep-2 cells through decreased expression of E-cadherin, and increased expression of
mesenchymal markers N-cadherin, vimentin, fibronectin, and α-SMA (Yang 2014).
Likewise, in a study of urothelial cells, long-term arsenic exposure led to increased Sox2
expression, concurrent with the aforementioned hallmarks of EMT; decreased E-cadherin,
and increased N-cadherin and vimentin expression (Ooki 2018).
These previous studies, combined with the findings of the current study, suggest
that arsenic may induce N-cadherin expression through increased Sox2 levels, maintaining
neural stem cell pluripotency through an EMT-like mechanism.
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5. Conclusion

A chronic arsenic exposure of 0.1 µM inorganic arsenic for 32 weeks was shown
to impair cellular differentiation and induce an EMT-like phenotype in P19 mouse
embryonic stem cells. Consistently elevated Sox2 protein and Sox2/Oct4 mRNA
expression, in conjunction with decreased Gad2 and doublecortin levels is indicative of
pluripotency maintenance and diminished differentiation. Further, arsenic exposure led to
temporally increased protein expression and altered patterning of the EMT marker, Ncadherin. Taken as a whole, chronic, low-level arsenic exposure appears to utilize an EMTlike mechanism to impair neural differentiation and maintain pluripotency through delayed
neuroblast migration. This notion is supported by increased expression of N-cadherin,
known to be implicated in hindering neuroblast migration; as well as decreased expression
of the neuronal migration marker, doublecortin (Zhang 2010, Francis 1999).
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Figure legends
Fig. 1. Effect of arsenic on stem cell morphology through 32 weeks of exposure. Shown
are representative images of day 9 control and 0.1 µM (7.5ppb) arsenic-exposed
differentiated cells at weeks 0, 16, and 32 of exposure. Arrows show elongating and
differentiating cells.
Fig. 2. Effect of arsenic exposure on neural, pluripotency, and oxidative stress-related
transcripts. (A.) Transcript expression following a nine day acute exposure to 0.5 µM
(37.5ppb) arsenic exposure was quantified by qPCR. Data was normalized to Gapdh and
is expressed as the average 2^ddCt for each group (n=3 flasks). Values of control and
arsenic-treated samples were compared at each respective time point, and all expression
fold changes used week 0 control samples as the reference. Statistical differences (*) were
determined using Student’s t-test (p<0.05). (B.) Transcript expression following a nine day
acute exposure to 0.1 µM (7.5ppb) arsenic exposure was quantified by qPCR. Data was
normalized to Gapdh and is expressed as the average 2^ddCt for each group (n=3 flasks).
Values of control and arsenic-treated samples were compared at each respective time point,
and all expression fold changes used week 0 control samples as the reference. Statistical
differences (*) were determined using Student’s t-test (p<0.05).
Fig. 3. Arsenic exposure increases Sox2/Oct4 transcript expression. Transcript levels
were quantified by qPCR. Independent data sets of Sox2 and Oct4 were normalized to
Gapdh, then respective fold changes were averaged together and expressed as the mean
2^ddCt for each group (n=3 flasks). Values of control and arsenic-treated samples were
compared at each respective time point, and all expression fold changes used week 0
control samples as the reference. Statistical differences (*) were determined using
Student’s t-test (p<0.05).
Fig. 4: Arsenic exposure reduces the transcript expression of the neural progenitor
gene Doublecortin. Transcript expression of Doublecortin was quantified by qPCR. Data
was normalized to Gapdh and is expressed as the average 2^ddCt for each group (n=3
flasks). Values of control and arsenic-treated samples were compared at each respective
time point, and all expression fold changes used week 0 control samples as the reference.
Statistical differences (*) were determined using Student’s t-test (p<0.05).
Fig. 5: Sox2 expression increased resulting from arsenic exposure. (A.) Representative
images of Sox2 expression in day 5 control and 0.1 µM (7.5ppb) arsenic exposed embryoid
bodies at weeks 0, 8, 16, 20, 28, and 32 of exposure. (B.) The integrated density function
in ImageJ was used to assess relative fluorescence (n=3-4 per exposure group) at 20x
magnification. Statistical differences (*) were determined using Student’s t-test (p<0.05).
(C.) The levels of Sox2 protein expression were determined by immunoblotting at week 20
and week 24 of arsenic exposure, with representative blots (n=4) shown. Sox2 specific
antibodies were used to detect total protein levels. (D.) Sox2 protein levels at week 20 and
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week 24 were normalized to Gapdh and relative expression (n=4 per exposure group) was
assessed using the integrated density function in ImageJ. Statistical differences (*) were
determined using Student’s t-test (p<0.05).
Fig. 6: Arsenic exposure results in increased N-cadherin expression and grouping of
N-cadherin positive cells. (A.) Representative images of N-cadherin expression in day 5
control and 0.1 µM (7.5ppb) arsenic exposed embryoid bodies at weeks 0, 8, 16, 20, 28,
and 32 of exposure. (B.) The integrated density function in ImageJ was used to assess
relative fluorescence (n=3-4 per exposure group) at 20x magnification. Statistical
differences (*) were determined using Student’s t-test (p<0.05). (C.) Representative images
of E-cadherin expression in day 5 control and 0.1 µM (7.5ppb) arsenic exposed embryoid
bodies at weeks 0, 8, 16, 20, 28, and 32 of exposure. (D.) The integrated density function
in ImageJ was used to assess relative fluorescence (n=3-4 per exposure group) at 20x
magnification. Statistical differences (*) were determined using Student’s t-test (p<0.05).
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Table 2.1: Genes of interest quantified by qPCR.
Gene

Sequence

Melting
Temp.
(ºC)

Function

Forward

Reverse

Gapdh

5'-tgcgacttcaacagcaactc-3'

5'-atgtaggccatgaggtccac-3'

56

Normalization

Sox2

5'-aggcagagaagagagtgtttg-3'

5'-cttctctcctttctttctctctcc-3'

55

Pluripotency

Oct4

5'-cctacagcagatcactcacatc-3'

5'-tgtccctgtagcctcatact-3'

58

Pluripotency

Gad2

5'- gtctgcttctggtttgtacct-3'

5'-gtggtcccatactccatcattc -3'

56

GABAproduction

Doublecortin
(DCX)

5'-ggtgacggatgaatggactt-3'

5'-cgtaccttcttggccttctt-3'

56

Neural
Differentiation

Nrf2

5'-ctccgtggagtcttccatttac-3'

5'-gcactatctagctcctccatttc-3'

58

Oxidative
Stress

Heme
Oxygenase
(Hmox)

5'-gtacacatccaagccgagaa-3'

5'-tggtacaaggaagccatcac-3'

58

Oxidative
Stress
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Table 2.2 Cell lineage profiler array differential expression of select genes

Gene symbol and
function
Pluripotency
Sox2
Oct4

Week 8
Week 32
Expression in
Expression in
Change in arsenicarsenic/control cells arsenic/control cells exposed cells
1.9
2.7

3.3
0.7

Nanog

0.8

0.8

Ectoderm and
neuroectoderm
germ cells
Fgf5
FoxD3
Otx2
Zic1
Gbx2

2.2
1.5
1.5
1.5
3.7

1.4
1.2
0.5
1.0
1.3

Differentiated
neurons
Dcx
Prom1
Gad2

0.1
0.1
0.1

0.4
0.7
0.1

Mesoderm germ
cells
Gata2
Tbxt

0.6
0.1

1.8
0.6

ND
3.3

0.1
0.6

Differentiated
muscles
Myh1
Myh7
ND = not detectable
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B.
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Fig. 3

69

Fig. 4
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Control
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Arsenic

Week 0

A.

Week 8

Week 16

Week 20

Week 28

Week 32

71

B.

72

C.
Control

Arsenic

kDa
34

Sox2

37

GAPDH

Week 20

Control

Arsenic

kDa
34

Sox2

37

GAPDH

Week 24

D.

Sox2 Expression

Day 5
73

Control

Fig. 6

Week 0
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Week 32

74

Arsenic

B.
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Arsenic

Control

C.

Week 0
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Week 16

Week 20

Week 28

Week 32

76

D.
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Chapter Three
Conclusion
Many studies have reported developmental deficits including decreased birthweight
and lowered intelligence quotient (IQ) scores in children following chronic arsenic
exposure during embryonic and fetal development (Rahman 2009, Wasserman 2014).
Arsenic concentrations in drinking water are known to be substantially higher than the
resulting blood concentrations following ingestion. However, arsenic will readily cross the
blood-placenta-barrier, and concentrations in maternal blood are often comparable to levels
found in cord blood (Concha 1998, Jin 2006). An epidemiological study of an Andean
population in Argentina with concentrations of 200 µg/L arsenic in drinking water reported
that median maternal blood arsenic concentrations were 11 µg/L, while median cord blood
levels were 9 µg/L arsenic (Concha 1998). Therefore, the 7.5 µg/L arsenic concentration
of the current study is a highly relevant concentration for the investigation of arsenicinduced developmental impairment.
While it is accepted that arsenic impacts development, there is much less
understood about how arsenic causes these deficits at the molecular level. This study found
that a chronic, in vitro 0.1 µM arsenic exposure maintains ESC pluripotency and impairs
neuroblast differentiation. The expression of Sox2/Oct4 mRNA levels were first shown to
be elevated at week 8 by 1.7-fold, while Sox2 protein expression began to be upregulated
at week 16 of exposure by 1.4-fold and remained significantly elevated through the
remaining exposure. Protein expression of N-cadherin beginning at week 20 by 1.3-fold
also remained significantly increased through week 32 of exposure suggesting that an
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EMT-like mechanism may be at least partially responsible for maintained pluripotency.
Interestingly, these trends were exacerbated the longer the exposure continued. Further,
decreased expression of the neurodevelopmental marker doublecortin was observed at
week 12 and week 20 of exposure.
The current findings should be highly relevant to the field of public health as it is
not uncommon for concentrations of arsenic greater than 200 µg/L to be found throughout
the world in countries like Argentina and Bangladesh, as well as some areas of the United
States (Concha 1998, Flanagan 2012, Nielson 2010). Though it has been shown previously
that arsenic exposure can impair cellular differentiation and induce EMT, to our current
knowledge this has not been shown in a chronic study at a level lower than the current
drinking water standard of 10µg/L (10 ppb) (EPA 2001). This maintained pluripotency and
EMT-like phenotype in embryonic stem cells may play a role in observed developmental
deficits due to chronic in -utero arsenic exposure. For instance, the observed delayed and/or
impaired neural differentiation of cells in-vitro may be indicative of delayed neural-fate
determination in developing embryos, leading to learning deficits and reduced IQ scores.
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